Article

BioBladder – a national longitudinal sampling study providing a comprehensive framework to precision oncology in urothelial cancer

2026-06-09

Abstract excerpt

<title>Abstract</title> <p>Background Urothelial cancer (UC) represents a major global health burden with more than 600,000 new cases and over 220,000 deaths annually. Although many tumors present at superficial stages, patients remain at lifelong risk of progression to muscle-invasive bladder cancer (MIBC) and metastatic urothelial cancer (mUC). Despite therapeutic advances, including perioperative immune-check...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3f3581e1-54d0-586f-aa8e-1bd266305b6d
DOI: 10.21203/rs.3.rs-9915229/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

BioBladder – a national longitudinal sampling study providing a comprehensive framework to precision oncology in urothelial cancerDOI 10.21203/rs.3.rs-9915229/v1Read

Urine-derived bladder cancer organoids (urinoids) as tool for cancer longitudinal response monitoring and therapy adaptationSemantic proximity Read

The evolving landscape and clinical utility of circulating tumor DNA across the spectrum of urothelial carcinoma: A systematic review and framework for clinical integration.Semantic proximity Read

FOLLOW-U; study protocol evaluating oncological systemic treatment response of advanced bladder cancer patients using urinoidsSemantic proximity Read

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing.Semantic proximity Read

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.Semantic proximity Read

Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current DevelopmentSemantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash is Another Man’s TreasureSemantic proximity Read

Liquid Biopsy in Genitourinary Cancers: Circulating Tumor DNA as a Predictive Biomarker for Treatment Selection and Resistance MonitoringSemantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice – from biobank to RNA-sequencing in real timeSemantic proximity Read